Fluidigm Corporation (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. acquired 22,363 shares of the company’s stock in a transaction on Monday, October 23rd. The shares were acquired at an average cost of $5.47 per share, for a total transaction of $122,325.61. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Thursday, October 19th, Levin Capital Strategies, L.P. acquired 60,000 shares of Fluidigm Corporation stock. The shares were acquired at an average cost of $4.55 per share, for a total transaction of $273,000.00.
  • On Tuesday, October 17th, Levin Capital Strategies, L.P. acquired 144,200 shares of Fluidigm Corporation stock. The shares were acquired at an average cost of $4.59 per share, for a total transaction of $661,878.00.
  • On Monday, October 9th, Levin Capital Strategies, L.P. acquired 50,000 shares of Fluidigm Corporation stock. The shares were acquired at an average cost of $4.59 per share, for a total transaction of $229,500.00.
  • On Tuesday, October 10th, Levin Capital Strategies, L.P. acquired 95,843 shares of Fluidigm Corporation stock. The shares were acquired at an average cost of $4.57 per share, for a total transaction of $438,002.51.
  • On Tuesday, September 12th, Levin Capital Strategies, L.P. acquired 60,000 shares of Fluidigm Corporation stock. The shares were acquired at an average cost of $5.25 per share, for a total transaction of $315,000.00.
  • On Thursday, August 17th, Levin Capital Strategies, L.P. purchased 465 shares of Fluidigm Corporation stock. The shares were bought at an average price of $3.66 per share, for a total transaction of $1,701.90.
  • On Thursday, August 10th, Levin Capital Strategies, L.P. purchased 4,003,129 shares of Fluidigm Corporation stock. The shares were bought at an average price of $3.30 per share, for a total transaction of $13,210,325.70.
  • On Wednesday, August 9th, Levin Capital Strategies, L.P. purchased 1,549 shares of Fluidigm Corporation stock. The shares were bought at an average price of $3.18 per share, for a total transaction of $4,925.82.

Shares of Fluidigm Corporation (FLDM) traded up 3.090% during midday trading on Tuesday, hitting $5.639. The stock had a trading volume of 513,772 shares. The stock’s 50 day moving average price is $5.01 and its 200 day moving average price is $4.49. Fluidigm Corporation has a 12 month low of $2.52 and a 12 month high of $8.69. The firm’s market cap is $165.87 million.

Fluidigm Corporation (NASDAQ:FLDM) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.60) by $0.02. Fluidigm Corporation had a negative return on equity of 121.04% and a negative net margin of 74.05%. The firm had revenue of $23.90 million for the quarter, compared to analysts’ expectations of $23.50 million. During the same period in the previous year, the firm earned ($0.63) EPS. The business’s quarterly revenue was down 15.2% on a year-over-year basis. On average, equities analysts forecast that Fluidigm Corporation will post ($1.95) EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Levin Capital Strategies, L.P. Purchases 22,363 Shares of Fluidigm Corporation (FLDM) Stock” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/24/levin-capital-strategies-l-p-purchases-22363-shares-of-fluidigm-corporation-fldm-stock.html.

Several hedge funds have recently bought and sold shares of the company. State Street Corp lifted its position in shares of Fluidigm Corporation by 6.2% during the 2nd quarter. State Street Corp now owns 499,524 shares of the medical research company’s stock valued at $2,017,000 after buying an additional 29,110 shares in the last quarter. PDT Partners LLC lifted its position in shares of Fluidigm Corporation by 56.0% during the 2nd quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after buying an additional 9,800 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Fluidigm Corporation by 9.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 136,003 shares of the medical research company’s stock valued at $549,000 after buying an additional 11,557 shares in the last quarter. Virtu KCG Holdings LLC purchased a new position in shares of Fluidigm Corporation during the 2nd quarter valued at about $105,000. Finally, Northern Trust Corp lifted its position in shares of Fluidigm Corporation by 7.2% during the 2nd quarter. Northern Trust Corp now owns 406,560 shares of the medical research company’s stock valued at $1,642,000 after buying an additional 27,400 shares in the last quarter. 88.61% of the stock is currently owned by hedge funds and other institutional investors.

Separately, ValuEngine upgraded Fluidigm Corporation from a “strong sell” rating to a “sell” rating in a research report on Monday.

About Fluidigm Corporation

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm Corporation (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.